Summary of Classification and Labelling
Notified classification and labelling
General Information
219-112-8 |
(17β).-hydroxyandrosta-1,4-dien-3-one acetate |
2363-59-9 |
Notified classification and labelling according to CLP criteria
Carc. 2 |
H351
|
H351
|
|
GHS08 Wng
|
|
|
|
|
38 |
|
View details
|
STOT RE 2 |
H373
(CUST-N11.005228...)
(oral)
|
H373
|
STOT RE 2 |
H373
(other:CUST-N11....)
(oral)
|
H373
|
Number of Aggregated Notifications: 1